Get the Stockscreener App
5.59
0.18%
-0.010
Clinuvel Pharmaceuticals Limited American Depositary Shares Stock (CUVL) Forecast
The Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.8196, representing a +4.11% increase from the current price of $5.59. The highest analyst price target is $6.935, and the lowest is $4.7041.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CUVL Price Target
Average 3.8905
(-30.40% Downside)
Is Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 40.17 | Neutral |
| STOCH(9,6) | 39.40 | Neutral |
| STOCHRSI(14) | 47.59 | Neutral |
| MACD(12,26) | -0.1691 | Buy |
| ADX(14) | 18.93 | Neutral |
| William %R | -87.13 | Buy |
| CCI(14) | -88.48 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.767
Sell
|
5.7356
Sell
|
| MA20 |
5.795
Sell
|
5.8536
Sell
|
| MA50 |
6.3237
Sell
|
6.3194
Sell
|
| MA100 |
3.5839
Buy
|
0.00
Buy
|
| MA200 |
1.792
Buy
|
0.00
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, CUVL could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on CUVL, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 40.17 indicates that CUVL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 39.4 indicates that CUVL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 47.59 indicates that CUVL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.93 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -88.48 indicates that CUVL is still oversold but not to an extreme extent.
Long-term CUVL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Clinuvel Pharmaceuticals Limited American Depositary Shares financial reports and earnings history, Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) stock could reach $10.15 by 2030, $56.22 by 2040 and $98.90 by 2050. See the projected annual prices until 2050 of the Clinuvel Pharmaceuticals Limited American Depositary Shares stock below:
- Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) is expected to reach an average price of $28.91 in 2035, with a high prediction of $30.79 and a low estimate of $28.97. This indicates an $417.16% rise from the last recorded price of $5.59.
- Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) stock is projected to chart a bullish course in 2040, with an average price target of $54.45, representing an $873.99% surge from its current level. The forecast ranges from a conservative $54.60 to a sky-high $56.22.
- Our analysts predict Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) to jump 1,385% by 2045, soaring from $70.15 to an average price of $83.01, potentially reaching $85.65. While $70.15 is the low estimate, the potential upside is significant.
- Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) stock is expected to climb by 2050, reaching an average of $92.44, a $1,554% jump from its current level. However, a wide range of estimates exists, with high and low targets of $98.90 and $92.90, respectively, highlighting the market's uncertainty.
Clinuvel Pharmaceuticals Limited American Depositary Shares Stock (CUVL) Year by Year Forecast
Clinuvel Pharmaceuticals Limited American Depositary Shares Stock (CUVL) Price Forecast for 2026
The predicted value for Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) in 2026 is set at an average of $6.315. Estimates vary from a peak of $8.20 to a trough of $4.4301, indicating an +12.97% surge from the present price of $5.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $5.2931 | $4.7041 | $6.935 | -5.31% |
| December, 2026 | $4.8091 | $4.4301 | $4.9821 | -13.97% |
Clinuvel Pharmaceuticals Limited American Depositary Shares Stock (CUVL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) is $2.8774, with a high forecast of $5.6701 and a low forecast of $0.0847. This indicates an -48.53% decrease from the last price of $5.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.808 | $3.528 | $5.47 | -31.88% |
| February, 2027 | $3.6301 | $3.556 | $5.6701 | -35.06% |
| March, 2027 | $3.2902 | $3.2602 | $4.2795 | -41.14% |
| April, 2027 | $2.87 | $2.87 | $4.11 | -48.66% |
| May, 2027 | $2.3651 | $2.187 | $4.4051 | -57.69% |
| June, 2027 | $2.3332 | $2.1762 | $3.0526 | -58.26% |
| July, 2027 | $2.2514 | $2.0903 | $2.6343 | -59.73% |
| August, 2027 | $2.6641 | $0.846 | $2.8441 | -52.34% |
| September, 2027 | $1.1183 | $0.9662 | $3.1402 | -79.99% |
| October, 2027 | $1.5024 | $0.9204 | $1.5024 | -73.12% |
| November, 2027 | $0.3851 | $0.0852 | $1.39 | -93.11% |
| December, 2027 | $0.3853 | $0.0847 | $1.8752 | -93.11% |
Clinuvel Pharmaceuticals Limited American Depositary Shares Stock (CUVL) Price Forecast for 2028
In 2028, Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) is projected to reach an average price of $2.4486, with a high projection of $4.8578 and a low estimate of $0.0394. This indicates an -56.20% fall from the last price of $5.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.3706 | $0.0894 | $0.3706 | -93.37% |
| February, 2028 | $1.2569 | $0.0394 | $0.8919 | -77.52% |
| March, 2028 | $1.5257 | $1.1538 | $0.9457 | -72.71% |
| April, 2028 | $1.3894 | $1.3116 | $1.1194 | -75.14% |
| May, 2028 | $2.8969 | $1.1523 | $1.4969 | -48.18% |
| June, 2028 | $2.6947 | $2.4377 | $2.2208 | -51.79% |
| July, 2028 | $2.5594 | $2.5124 | $2.2894 | -54.22% |
| August, 2028 | $3.93 | $2.2652 | $2.69 | -29.70% |
| September, 2028 | $2.4717 | $3.7217 | $3.5359 | -55.78% |
| October, 2028 | $3.6113 | $3.7013 | $3.4734 | -35.40% |
| November, 2028 | $3.313 | $3.378 | $3.4593 | -40.73% |
| December, 2028 | $4.8268 | $5.1267 | $4.8578 | -13.65% |
Clinuvel Pharmaceuticals Limited American Depositary Shares Stock (CUVL) Price Forecast for 2029
The 2029 price forecast for Clinuvel Pharmaceuticals Limited American Depositary Shares Stock (CUVL) is $6.9905 on average, with a high prediction of $9.49 and a low estimate of $4.4909. This represents an +25.05% increase from the previous price of $5.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.9213 | $4.9924 | $4.6835 | -11.96% |
| February, 2029 | $4.157 | $4.617 | $4.6303 | -25.64% |
| March, 2029 | $6.5448 | $4.4909 | $6.1798 | +17.08% |
| April, 2029 | $5.7494 | $6.2194 | $6.1297 | +2.85% |
| May, 2029 | $5.549 | $5.879 | $5.8893 | -0.73% |
| June, 2029 | $8.2609 | $5.6038 | $6.8609 | +47.78% |
| July, 2029 | $7.7554 | $7.5736 | $7.5018 | +38.74% |
| August, 2029 | $7.239 | $7.2681 | $7.0972 | +29.50% |
| September, 2029 | $9.37 | $6.7167 | $8.13 | +67.62% |
| October, 2029 | $9.0194 | $8.8576 | $8.8238 | +61.35% |
| November, 2029 | $8.367 | $8.457 | $8.4213 | +49.68% |
| December, 2029 | $10.73 | $7.8296 | $9.49 | +91.95% |
Clinuvel Pharmaceuticals Limited American Depositary Shares Stock (CUVL) Price Forecast for 2030
Clinuvel Pharmaceuticals Limited American Depositary Shares Stock (CUVL) is expected to reach an average price of $11.53 in 2030, with a high forecast of $14.11 and a low forecast of $8.9424. This signifies an +106.21% surge from the last price of $5.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $8.8915 | $10.14 | $10.15 | +59.06% |
| February, 2030 | $9.753 | $9.9002 | $9.6673 | +74.47% |
| March, 2030 | $8.6846 | $9.1446 | $9.3859 | +55.36% |
| April, 2030 | $11.34 | $8.9424 | $11.47 | +102.89% |
| May, 2030 | $10.66 | $11.13 | $10.91 | +90.65% |
| June, 2030 | $10.15 | $10.48 | $10.72 | +81.62% |
| July, 2030 | $13.15 | $10.06 | $12.79 | +135.33% |
| August, 2030 | $12.74 | $12.71 | $12.64 | +127.89% |
| September, 2030 | $11.30 | $11.63 | $11.93 | +102.21% |
| October, 2030 | $14.97 | $11.17 | $13.57 | +167.73% |
| November, 2030 | $14.08 | $13.99 | $14.11 | +151.87% |
| December, 2030 | $13.09 | $13.12 | $13.41 | +134.14% |
1.64%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):